valsartan/hydrochlorothiazide krka
krka, d.d., novo mesto - valsartanas/hidrochlorotiazidas - plėvele dengtos tabletės - 320 mg/25 mg; 320 mg/12,5 mg; 160 mg/12,5 mg; 80 mg/12,5 mg; 160 mg/25 mg - valsartan and diuretics
amlodipine/valsartan ingen pharma
sia ingen pharma - amlodipinas/valsartanas - plėvele dengtos tabletės - 5 mg/160 mg; 10 mg/160 mg - valsartan and amlodipine
suvartar hct
sandoz d.d. - valsartanas/hidrochlorotiazidas - plėvele dengtos tabletės - 320 mg/25 mg; 320 mg/12,5 mg; 160 mg/12,5 mg; 80 mg/12,5 mg; 160 mg/25 mg - valsartan and diuretics
baycox iron
bayer animal health gmbh - iron(iii) ion, toltrazuril - toltrazurilio, deriniai - kiaulės (paršeliai) - dėl vienalaikio prevencijos klinikiniai požymiai, coccidiosis (pvz., viduriavimas) į naujagimių paršelių ūkiuose su patvirtinta istorijos coccidiosis sukelia cystoisospora suis), ir prevencijos geležies stokos anemija.
yasnal
krka, d.d., novo mesto - donepezilo hidrochloridas - plėvele dengtos tabletės - 10 mg; 5 mg - donepezil
alzepil
egis pharmaceuticals plc - donepezilas - burnoje disperguojamos tabletės - 5 mg; 10 mg - donepezil
lonsurf
les laboratoires servier - trifluridine, tipiracil hidrochloridas - kolorektaliniai navikai - antinavikiniai vaistai - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
glucose b.braun
b.braun melsungen ag - gliukozė - infuzinis tirpalas - 100 mg/ml; 50 mg/ml - carbohydrates
tacrolimus pharmaswiss
pharmaswiss Česká republika s.r.o. - takrolimuzas - kietosios kapsulės - 1 mg; 0,5 mg - tacrolimus
topamax
johnson & johnson, uab - topiramatas - plėvele dengtos tabletės - 200 mg; 100 mg; 50 mg; 25 mg - topiramate